MedPath

Essential Fats for Enhancing Cognitive Thinking (EFFECT) Study

Not Applicable
Recruiting
Conditions
Cognitive Impairment
Cognitive Decline
Interventions
Other: Walnuts
Other: Simply White Diary-free chocolate bar
Registration Number
NCT06223672
Lead Sponsor
Ohio State University
Brief Summary

The proposed research is a randomized crossover trial designed to assess changes in postprandial cognitive function and the gut-brain axis in adults with subjective cognitive complaints who consume 1 study snack per day for 1 week.

Detailed Description

Study objective including

1. To measure the impact of dietary fats on postprandial cognitive function in adults who report subjective cognitive complaints.

2. To assess the effect of dietary fat consumption on the gut-brain axis in relationship to cognitive function.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Subjective cognitive impairment
  • BMI ≥30 kg/m2
  • HbA1C <6.5%
Exclusion Criteria
  • Diagnosis og cognitive impairment or dementia
  • Montreal Cognitive Assessment (MoCA) score of <26
  • Current or previous diagnosis of Diabetes or use of diabetes medications
  • Current diagnosis of or current treatment of cancer other than non-melanoma skin cancer
  • Gastrointestinal diseases or disorders (including pancreatic and gastric bypass surgery) where consumption of the study foods would be contraindication or where the disease or disorder could negatively affect nutrient absorption and/or would prevent participants from tolerating the study foods
  • Hyperthyroidism diagnosis
  • Food Allergy or intolerances
  • Any dietary restriction where consumption of the study foods, study meals/snack or meal challenge or any ingredient would be contraindicated
  • Use of some oil supplements in the past 4 weeks prior to enrolling
  • Pregnancy and lactation
  • Inability to access veins for venipuncture
  • Antibiotic use in the past month
  • Psychostimulant or nootropic medication use
  • Current use of supplements or medications for weight loss or following a weight loss program
  • Severe or uncontrolled autoimmune diseases
  • Current or previous diagnosis of severe kidney failure, liver cirrhosis and some pulmonary diseases
  • Heart disease events (including stroke or heart attack) within last 3 months prior to enrollment
  • Alcohol or drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
WalnutsWalnutsconsumption of walnuts every day
White chocolate-style barSimply White Diary-free chocolate barconsumption of a white chocolate-style bar every day
Primary Outcome Measures
NameTimeMethod
Cognitive function measured using the National Institutes of Health Toolbox for the Assessment of Neurological and Behavioral Function Cognitive Battery (NIHTB-CB)Week 0 and Week 5

To determine the impact of consuming the study dietary fats as part of a high fat meal on postprandial cognitive function

Secondary Outcome Measures
NameTimeMethod
Change in Cognitive function measured using the National Institutes of Health Toolbox for the Assessment of Neurological and Behavioral Function Cognitive Battery (NIHTB-CB)Week 0, Week 1, Week 5 and Week 6

To assess changes in cognitive function after consuming 1 serving of the dietary fats every day for 1 week

Changes in fecal Microbiota diversityWeek 0, Week 1, Week 5 and Week 6

To assess changes in microbiota diversity of fecal samples after consuming 1 serving of the dietary fats every day for 1 week

Trial Locations

Locations (1)

The Ohio State University

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath